Survivin expression and serum levels in pancreatic cancer

World Journal of Surgical Oncology

Volumn 13, Issue 1, 2015, Pages

  Dong, He ^a   Qian, Dongmeng ^a   Wang, Yaqiu ^b   Meng, Lingsheng ^c   Chen, Dong ^a   Ji, Xiangyu ^a   Feng, Wei ^a  

^a QINGDAO UNIVERSITY   (China)

^b QINGDAO WOMEN AND CHILDREN S HOSPITAL   (China)

^c People s Hospital of Zhangqiu   (China)

Author keywords

Pancreatic ductal adenocarcinoma; Prognosis; Survivin

Indexed keywords

FORMALDEHYDE; PARAFFIN; SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PERINEURAL INVASION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEX DIFFERENCE; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; VOLUNTEER; BLOOD; CANCER STAGING; CARCINOMA, PANCREATIC DUCTAL; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREATIC NEOPLASMS; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR INVASION;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 84935918578     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/s12957-015-0605-7     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. Warshaw AL, Fernandez-del CC. Pancreatic carcinoma. N Engl J Med. 1992;326:455-65.
3. Li HY, Cui ZM, Chen J, Guo XZ, Li YY. Pancreatic cancer: diagnosis and treatments. Tumour Biol. 2015;36:1375-84.
4. Surlin V, Bintintan V, Petrariu FD, Dobrin R, Lefter R, Ciobič A, et al. Prognostic factors in resectable pancreatic cancer. Rev Med Chir Soc Med Nat Iasi. 2014;118:924-31.
5. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91:586-94.
6. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med. 1993;328:1433-7.
7. Talamini G, Falconi M, Bassi C, Sartori N, Salvia R, Caldiron E. Incidence of cancer in the course of chronic pancreatitis. Am J Gastroenterol. 1999;94:1253-60.
8. Maisonneuve P, Lowenfels AB. Chronic pancreatitis and pancreatic cancer. Dig Dis. 2002;20:32-7.
9. Dzeletovic I, Harrison ME, Crowell MD, Pannala R, Nguyen CC, Wu Q, et al. Pancreatitis before pancreatic cancer: clinical features and influence on outcome. J Clin Gastroenterol. 2014;48:801-5.
10. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev. 1999;13:239-52.
11. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol. 2002;3:401-10.
12. Verdecia MA, Huang H, Dutil E, Kaiser DA, Hunter T, Noel JP. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Biol. 2000;7:602-8.
13. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917-21.
14. Cheung CH, Huang CC, Tsai FY, Lee JY, Cheng SM, Chang YC, et al. Survivin-biology and potential as a therapeutic target in oncology. Onco Targets Ther. 2013;6:1453-62.
15. Ito R, Asami S, Motohashi S, Ootsuka S, Yamaguchi Y, Chin M, et al. Significance of survivin mRNA expression in prognosis of neuroblastoma. Biol Pharm Bull. 2005;28:565-8.
16. Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, et al. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene. 2000;19:617-23.
17. Goossens-Beumer IJ, Zeestraten EC, Benard A, Christen T, Reimers MS, Keijzer R, et al. Clinical prognostic value of combined analysis of Aldh1, survivin, and EpCAM expression in colorectal cancer. Br J Cancer. 2014;110:2935-44.
18. Xu C, Yamamoto-Ibusuki M, Yamamoto Y, Yamamoto S, Fujiwara S, Murakami K, et al. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Breast Cancer. 2012;23:209-13.
19. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, et al. Expression of surviving in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer. 2001;95:92-5.
20. Rosato A, Menin C, Boldrin D, Dalla Santa S, Bonaldi L, Scaini MC, et al. Survivin expression impacts prognostically on NSCLC but not SCLC. Lung Cancer. 2013;79:180-6.
21. Abdel-Aziz A, Mohamed MA, Akl FM, Taha AN. Survivin expression in medulloblastoma: a possible marker for survival. Pathol Oncol Res. 2013;19:413-9.
22. Esh AM, Atfy M, Azizi NA, El Naggar MM, Khalil EE, Sherief L. Prognostic significance of survivin in pediatric acute lymphoblastic leukemia. Indian J Hematol Blood Transfus. 2011;27:18-25.
23. Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A, Shimosegawa T. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer. 2001;92:271-8.
24. Kami K, Doi R, Koizumi M, Toyoda E, Mori T, Ito D, et al. Survivin expression is a prognostic marker in pancreatic cancer patients. Surgery. 2004;136:443-8.
25. Ekeblad S, Lejonklou MH, Stålberg P, Skogseid B. Prognostic relevance of survivin in pancreatic endocrine tumors. World J Surg. 2012;36:1411-8.
26. Ren YQ, Zhang HY, Su T, Wang XH, Zhang L. Clinical significance of serum survivin in patients with pancreatic ductal adenocarcinoma. Eur Rev Med Pharmacol Sci. 2014;18:3063-8.
27. Li Y, Ma X, Wu X, Liu X, Liu L. Prognostic significance of survivin in breast cancer: meta-analysis. Breast J. 2014;20:514-24.